PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29689091-0	2018	Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients.	Erlotinib Hydrochloride	68-77	microRNA 133b	Homo sapiens	21-29	
29689091-4	2018	We found that miR-133b expression level better discriminated responder from non-responder patients to erlotinib.	Erlotinib Hydrochloride	102-111	microRNA 133b	Homo sapiens	14-22	
29689091-7	2018	The detection of miR-133b expression levels in tumors help in the identification of NSCLC patients with a better prognosis and who are likely to benefit from second and third-line therapy with erlotinib.	Erlotinib Hydrochloride	193-202	microRNA 133b	Homo sapiens	17-25